Your browser is no longer supported. Please, upgrade your browser.
Settings
INSM Insmed Incorporated daily Stock Chart
INSM [NASD]
Insmed Incorporated
Index- P/E- EPS (ttm)-3.04 Insider Own0.90% Shs Outstand77.50M Perf Week5.29%
Market Cap2.25B Forward P/E- EPS next Y-2.21 Insider Trans-10.86% Shs Float75.68M Perf Month142.57%
Income-188.20M PEG- EPS next Q-0.69 Inst Own75.90% Short Float5.47% Perf Quarter73.08%
Sales- P/S- EPS this Y-41.30% Inst Trans-1.10% Short Ratio3.01 Perf Half Y90.68%
Book/sh1.34 P/B21.69 EPS next Y18.10% ROA-85.50% Target Price37.38 Perf Year96.09%
Cash/sh1.18 P/C24.72 EPS next 5Y- ROE-130.40% 52W Range10.21 - 31.39 Perf YTD119.65%
Dividend- P/FCF- EPS past 5Y0.70% ROI- 52W High-6.29% Beta0.63
Dividend %- Quick Ratio3.70 Sales past 5Y- Gross Margin- 52W Low188.10% ATR1.59
Employees161 Current Ratio3.70 Sales Q/Q- Oper. Margin- RSI (14)72.49 Volatility3.07% 6.25%
OptionableYes Debt/Eq0.00 EPS Q/Q-21.50% Profit Margin- Rel Volume0.51 Prev Close29.06
ShortableYes LT Debt/Eq0.66 EarningsAug 03 BMO Payout- Avg Volume1.38M Price29.42
Recom1.80 SMA2031.53% SMA5065.07% SMA20079.52% Volume254,811 Change1.22%
Sep-05-17Reiterated Evercore ISI Outperform $28 → $40
Aug-17-17Initiated Evercore ISI Outperform $28
Jul-11-17Initiated Robert W. Baird Outperform $23
Mar-15-16Initiated Stifel Buy $23
Nov-09-15Downgrade UBS Buy → Neutral $35 → $18
Oct-06-15Reiterated H.C. Wainwright Buy $30 → $35
Jun-09-15Initiated Citigroup Neutral $27
Mar-26-14Reiterated HC Wainwright Buy $25 → $30
Jan-06-14Reiterated UBS Buy $17.50 → $31
Nov-11-13Initiated HC Wainwright Buy $25
Jun-19-13Initiated UBS Buy $17.50
Jun-18-13Initiated UBS Buy $17.50
Sep-16-11Initiated Wedbush Outperform $15
Sep-19-17 08:00AM  Insmed to Present at Two September Investor Conferences GlobeNewswire
Sep-12-17 12:26PM  As Insmed Reaches New Highs, Is Matinas Following in Its Footsteps? GuruFocus.com
Sep-11-17 04:01PM  Insmed Announces Closing of Public Offering GlobeNewswire
08:02AM  See what the IHS Markit Score report has to say about Insmed Inc. Markit
Sep-09-17 10:02AM  3 Biotech Stocks That Skyrocketed This Week: Can They Go Higher? Motley Fool
Sep-06-17 09:37PM  Insmed Announces Pricing of Public Offering of Common Stock GlobeNewswire +8.78%
08:50AM  How Insmed Is Capitalizing on Its Huge Late-Stage Success 24/7 Wall St.
08:31AM  Insmed Incorporated (INSM) Catches Eye: Stock Soars 119.6% Zacks
08:29AM  Biotech Stock Roundup: Cellectis Down on Clinical Hold, Insmed Soars on Positive Data Zacks
08:10AM  Today's Research Reports on Stocks to Watch: Insmed Inc. and XOMA Corporation ACCESSWIRE
06:49AM  Could These 2 Biotech Stocks Really Double Your Money? Motley Fool
Sep-05-17 04:55PM  Biotech stock doubles in single day after treatment for a rare lung disease has successful trial CNBC +119.61%
04:36PM  Why Insmed, Himax Technologies, and Yamana Gold Jumped Today Motley Fool
04:01PM  Insmed Announces Proposed Public Offering of Common Stock GlobeNewswire
02:28PM  Insmed soars on positive lung drug study results CNBC Videos
01:50PM  Here's Why Insmed Incorporated Is Skyrocketing Motley Fool
11:13AM  Why Did Insmed (INSM) Stock Skyrocket Today? Zacks
10:31AM  North Korea Threat Roars Back Into Focus and Wall Street Retreats TheStreet.com
09:50AM  Insmed More Than Doubles on Late-Stage Trial 24/7 Wall St.
09:41AM  UPDATED: Insmed shares skyrocket 130% on positive late-stage results for rare lung disease therapy MarketWatch
09:21AM  Stocks to Watch: Rockwell Collins, Disney, Boeing, H.B. Fuller, Insmed The Wall Street Journal
07:00AM  Insmed Announces Positive Top-Line Results from Phase 3 CONVERT Study of ALIS (Amikacin Liposome Inhalation Suspension) in Adult Patients with Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) GlobeNewswire
Aug-31-17 08:45AM  Options Traders Expect Huge Moves in Insmed (INSM) Stock Zacks
Aug-16-17 08:02AM  See what the IHS Markit Score report has to say about Insmed Inc. Markit
Aug-14-17 08:02AM  See what the IHS Markit Score report has to say about Insmed Inc. Markit +8.10%
Aug-12-17 08:02AM  See what the IHS Markit Score report has to say about Insmed Inc. Markit
Aug-11-17 10:50PM  Edited Transcript of INSM earnings conference call or presentation 3-Aug-17 12:30pm GMT Thomson Reuters StreetEvents
Aug-10-17 08:04AM  See what the IHS Markit Score report has to say about Insmed Inc. Markit
Aug-09-17 08:50AM  Are Options Traders Betting on a Big Move in Insmed (INSM) Stock? Zacks -5.07%
08:03AM  See what the IHS Markit Score report has to say about Insmed Inc. Markit
Aug-03-17 11:53PM  Insmed reports 2Q loss Associated Press -9.23%
07:30AM  Insmed Reports Second Quarter 2017 Financial Results and Provides Business Update GlobeNewswire
06:40AM  Investor Network: Insmed Incorporated to Host Earnings Call ACCESSWIRE
Jul-27-17 08:00AM  Insmed to Host Second Quarter 2017 Financial Results Conference Call on Thursday, August 3, 2017 GlobeNewswire
Jul-17-17 08:30AM  Implied Volatility Surging For Insmed, Inc. (INSM) Stock Options Zacks
Jul-12-17 08:00AM  Insmed to Host Analyst and Investor Day on July 19, 2017 GlobeNewswire
Jun-27-17 08:53AM  Options Traders Expect Huge Moves in Insmed (INSM) Stock Zacks
Jun-13-17 08:00AM  Insmed to Present at the JMP Securities Life Sciences Conference GlobeNewswire
Jun-08-17 08:00AM  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
May-18-17 01:05PM  Edited Transcript of INSM earnings conference call or presentation 3-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-15-17 07:00AM  Insmed Announces Key Additions to its Executive Management Team GlobeNewswire
May-04-17 07:26PM  Edited Transcript of INSM earnings conference call or presentation 3-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-03-17 08:10AM  Insmed reports 1Q loss Associated Press
08:02AM  Insmed Reports First Quarter 2017 Financial Results and Provides Business Update GlobeNewswire
07:15AM  Investor Network: Insmed Incorporated to Host Earnings Call Accesswire
Apr-28-17 08:46AM  Implied Volatility Surging for Insmed (INSM) Stock Options Zacks
Apr-27-17 07:00AM  Insmed to Present at the Deutsche Bank 42nd Annual Health Care Conference GlobeNewswire
Apr-26-17 07:00AM  Insmed to Host First Quarter 2017 Financial Results Conference Call on Wednesday, May 3, 2017 GlobeNewswire
Mar-21-17 08:58AM  Do Options Traders Know Something About Insmed Incorporated (INSM) Stock We Don't? Zacks -5.71%
Feb-28-17 01:04PM  INSMED INC Financials
08:00AM  Insmed to Present at the Cowen and Company 37th Annual Health Care Conference GlobeNewswire
Feb-23-17 04:21PM  Edited Transcript of INSM earnings conference call or presentation 23-Feb-17 1:30pm GMT Thomson Reuters StreetEvents
09:35AM  Insmed reports 4Q loss Associated Press
08:18AM  INSMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:12AM  INSMED INC Files SEC form 10-K, Annual Report
08:02AM  Insmed Reports Fourth Quarter 2016 Financial Results and Provides Business Update GlobeNewswire
07:07AM  Q4 2016 Insmed Inc Earnings Release - Before Market Open
Feb-16-17 07:00AM  Insmed to Host Fourth Quarter and Year-end 2016 Financial Results Conference Call on Thursday, February 23, 2017 GlobeNewswire
Feb-14-17 08:05AM  Insmed Inc. Extends ARIKAYCE Intellectual Property Protection with Issuance of New U.S. Patent GlobeNewswire
Jan-17-17 05:25PM  Lifshitz & Miller Law Firm Announces Investigation of Calamos Asset Management, Inc., CDI Corp., comScore, Inc., Earthstone Energy, Inc., Heritage Oaks Bancorp, Insmed Incorporated, OCI Partners LP and Vascular Solutions, Inc. PR Newswire
Jan-04-17 08:00AM  Insmed to Present at the 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-05-16 12:12PM  Hedge Funds Sour Slightly On Insmed Incorporated (INSM), But Remain Overweight Insider Monkey
12:12PM  Hedge Funds Sour Slightly On Insmed Incorporated (INSM), But Remain Overweight at Insider Monkey
Nov-28-16 02:15PM  Insmed, Inc. :INSM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016 -5.19%
Nov-14-16 08:00AM  Insmed to Participate at November Investor Conferences GlobeNewswire
Nov-04-16 03:05PM  Robbins Arroyo LLP Is Investigating the Officers and Directors of Insmed, Inc. (INSM) on Behalf of Shareholders Business Wire +8.20%
09:17AM  Edited Transcript of INSM earnings conference call or presentation 3-Nov-16 12:30pm GMT
Nov-03-16 08:34AM  Insmed reports 3Q loss -13.74%
08:06AM  INSMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal Office
08:03AM  INSMED INC Files SEC form 10-Q, Quarterly Report
08:02AM  Insmed Reports Third Quarter 2016 Financial Results and Provides Business Update GlobeNewswire
07:07AM  Q3 2016 Insmed Inc Earnings Release - Before Market Open
Oct-27-16 08:00AM  Insmed to Host Third Quarter 2016 Financial Results Conference Call on Thursday, November 3, 2016 GlobeNewswire
Oct-18-16 08:00AM  Insmed Announces Publication of Phase 2 Study of ARIKAYCE in Treatment-Refractory Nontuberculous Mycobacterial Lung Disease GlobeNewswire
Oct-05-16 07:31AM  AstraZeneca licenses respiratory drug to Insmed Reuters
07:06AM  INSMED INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
06:55AM  Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor GlobeNewswire
Sep-27-16 08:06AM  INSMED INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhi
08:00AM  Insmed Appoints Roger Adsett as Chief Commercial Officer GlobeNewswire
Sep-13-16 03:19PM  Insmed, Inc. :INSM-US: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016
Sep-12-16 06:38PM  DEADLINE TOMORROW: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Reminds Investors with Losses to Contact the Firm Accesswire +5.16%
03:00PM  FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Insmed Incorporated (INSM) & Lead Plaintiff Deadline - September 13, 2016 Accesswire
11:51AM  DEADLINE TOMORROW ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Insmed Incorporated and Reminds Investors with Losses to Contact the Firm Accesswire
10:36AM  DEADLINE TOMORROW: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Insmed Incorporated and a Lead Plaintiff Deadline of September 13, 2016 - INSM GlobeNewswire
Sep-10-16 11:18PM  SEPTEMBER 13 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Reminds Investors with Losses to Contact the Firm Accesswire
Sep-09-16 08:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Insmed Incorporated of Class Action Lawsuit and Upcoming Deadline - INSM Accesswire -5.38%
Sep-08-16 11:24AM  5-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm Accesswire
10:20AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action against Insmed Incorporated (INSM) & Lead Plaintiff Deadline - September 13, 2016 Accesswire
08:00AM  Insmed to Participate at September Investor Conferences GlobeNewswire
Sep-07-16 01:19PM  SHAREHOLDER ALERT Rosen Law Firm Reminds Insmed Incorporated Investors of Important September 13 Deadline in Class Action - INSM PR Newswire
10:25AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Insmed Incorporated of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 13, 2016 INSM GlobeNewswire
Sep-02-16 10:59AM  DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Reminds Investors with Losses to Contact the Firm Accesswire
10:00AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Insmed Incorporated (INSM) & Lead Plaintiff Deadline - September 13, 2016 GlobeNewswire
09:50AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Insmed Incorporated of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 13, 2016 Business Wire
Sep-01-16 01:39PM  APPROACHING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm Accesswire
12:19PM  DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Insmed Incorporated Of Upcoming Deadline GlobeNewswire
Aug-31-16 08:00AM  Insmed Announces Upcoming Presentations at European Respiratory Society 2016 International Congress GlobeNewswire
Aug-29-16 12:30PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm Accesswire
10:13AM  INSM SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Insmed Incorporated and a Lead Plaintiff Deadline of September 13, 2016 Business Wire
Aug-28-16 07:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Insmed Incorporated of Class Action Lawsuit and Upcoming Deadline INSM GlobeNewswire
Insmed Incorporated, a biopharmaceutical company, focuses on the development and commercialization of therapies for patients with rare diseases. The company's lead product candidate is ARIKAYCE or liposomal amikacin for inhalation, a formulation of amikacin that is in late-stage clinical development for adult patients with treatment refractory nontuberculous mycobacteria lung disease caused by Mycobacterium avium complex. It is also developing INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1, which has completed a Phase I clinical study for activating neutrophil serine proteases that are implicated in the pathology of chronic inflammatory lung diseases, such as non-cystic fibrosis bronchiectasis; and INS1009, an inhaled nanoparticle formulation of a treprostinil prodrug, which has completed a Phase I clinical study for treating rare pulmonary disorders, including pulmonary arterial hypertension. The company was founded in 1999 and is headquartered in Bridgewater, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HAYDEN DONALD J JRDirectorSep 07Option Exercise3.0315,00045,45071,131Sep 07 04:46 PM
HAYDEN DONALD J JRDirectorSep 07Sale30.0015,000450,00056,131Sep 07 04:46 PM
SHAROKY MELVIN MDDirectorSep 06Sale25.8425,000645,915225,728Sep 07 05:41 PM
HAYDEN DONALD J JRDirectorSep 05Option Exercise3.0330,00090,90071,131Sep 07 04:46 PM
HAYDEN DONALD J JRDirectorSep 05Sale29.5030,000885,00056,131Sep 07 04:46 PM
SHAROKY MELVIN MDDirectorSep 05Sale28.9125,000722,782250,728Sep 07 05:41 PM
Pellizzari Christine AGeneral Counsel & Corp. Sec.May 31Buy14.892,70040,20330,000Jun 01 04:07 PM
Pellizzari Christine AGeneral Counsel & Corp. Sec.May 30Buy15.237,300111,17927,300Jun 01 04:07 PM
Drechsler Andrew TChief Financial OfficerMar 01Option Exercise6.6530,000199,50025,000Mar 03 04:17 PM
Drechsler Andrew TChief Financial OfficerMar 01Sale16.5120,000330,2005,000Mar 03 04:17 PM
Pellizzari Christine AGeneral Counsel & Corp. Sec.Dec 15Buy12.8910,000128,90020,000Dec 16 04:41 PM
Pellizzari Christine AGeneral Counsel & Corp. Sec.Dec 14Buy12.7210,000127,20010,000Dec 16 04:41 PM
POTTER MYRTLE SDirectorDec 14Sale12.775,00063,8450Dec 15 09:07 AM
POTTER MYRTLE SDirectorDec 13Sale12.881,46618,8865,000Dec 15 09:07 AM
Drechsler Andrew TChief Financial OfficerNov 17Option Exercise6.655,00033,2505,000Nov 18 04:08 PM
Drechsler Andrew TChief Financial OfficerNov 14Option Exercise6.7945,000305,50025,000Nov 15 05:07 PM
Drechsler Andrew TChief Financial OfficerNov 14Sale14.6745,000660,1500Nov 15 05:07 PM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.Nov 09Option Exercise6.968,00955,7438,009Nov 09 04:31 PM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.Nov 09Sale13.258,009106,1190Nov 09 04:31 PM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.Nov 07Option Exercise6.9660,765422,92437,500Nov 09 04:31 PM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.Nov 07Sale11.7860,765715,8120Nov 09 04:31 PM